Treatment Response at 3–6 Months After 177Lu-DOTA-LM3 PRRT
| Total (n = 47) | PRRT-naïve (n = 14) | Previously treated with TOC/TATE PRRT (n = 33) | ||||
|---|---|---|---|---|---|---|
| Response | n | % | n | % | n | % |
| RECIST CT or MRI response | ||||||
| Complete response | 0 | 0 | 0 | 0 | 0 | 0 |
| Partial response | 17 | 36.2 | 10 | 71.4 | 7 | 21.2 |
| Stable disease | 23 | 48.9 | 3 | 21.4 | 20 | 60.6 |
| Progressive disease | 7 | 14.9 | 1 | 7.1 | 6 | 18.2 |
| Disease control rate | 40 | 85.1 | 13 | 92.9 | 27 | 81.8 |
| EORTC SSTR imaging response | ||||||
| Complete response | 2 | 4.3 | 1 | 7.1 | 1 | 3.0 |
| Partial response | 21 | 44.7 | 9 | 64.3 | 12 | 36.4 |
| Stable disease | 18 | 38.3 | 3 | 21.4 | 15 | 45.5 |
| Progressive disease | 6 | 12.8 | 1 | 7.1 | 5 | 15.2 |
| Disease control rate | 41 | 87.2 | 13 | 92.9 | 28 | 84.8 |